Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesi... ( Data support the therapeutic potentia...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> MEDICINE >> TECHNOLOGY

Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society

Date:10/1/2008

Data support the therapeutic potential of Amylin's integrated neurohormonal

approach to obesity pharmacotherapy

SAN DIEGO, Oct. 1 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) today announced that new data for its pipeline obesity candidates will be presented at the 2008 Annual Scientific Meeting of The Obesity Society in Phoenix October 3-7. The Obesity Society's annual meeting is one of the largest and most comprehensive scientific conferences in the field of obesity.

Amylin will present scientific data through 11 oral and poster presentations, showcasing progress in the company's obesity pipeline. In addition to Amylin's lead clinical-stage programs in obesity, pramlintide/metreleptin and AC2307, new findings will also be presented on various preclinical programs, including a new Y-family mimetic and Amylin's peptide hybrid (phybrid) platform. Additional information will be presented during two corporate-sponsored symposia focused on the emerging peptide hormone approach to the treatment of obesity and the new science and therapeutic research that shows promise to reduce the risk of cardiovascular disease associated with obesity and type 2 diabetes.

"We are excited to present our latest work on the obesity front at this year's Obesity Society meeting, and will be sharing compelling data that demonstrates how our programs have the potential to provide significant weight loss that can be sustained over time," said Daniel Bradbury, president and chief executive officer at Amylin Pharmaceuticals, Inc. "Our unique neurohormonal approach to obesity, and our deep expertise in peptide hormones, enables us to develop drugs that may help regulate how many calories we eat, burn and st
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7
Related medicine technology :

1. Amylin Pharmaceuticals Initiates Phase 2B Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment in Obesity
2. Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings
3. Critical Pharmaceuticals Enter Sustained Release hGH Arena
4. Anadys Pharmaceuticals to Present at the JMP Securities Healthcare Focus Conference
5. Potentia Pharmaceuticals Announces Positive Safety Data and Study Expansion in Phase I Trial for Lead Drug Candidate POT-4
6. Quark Pharmaceuticals Announces First RNAi Drug Candidate Having a Novel, Proprietary Structure Covered by Quark Intellectual Property
7. Lotus Pharmaceuticals, Inc.s New Drug Laevo-Bambutero Begins Evaluation for Clinical Trials
8. VIA Pharmaceuticals Completes Patient Visits in Phase 2 Acute Coronary Syndrome (ACS) Trial
9. QuatRx Pharmaceuticals Announces Additional Data From Phase 3 Study for Ophena(TM) (Ospemifene Tablets) Showing Improvements in Clinical Symptoms of Vulvovaginal Atrophy
10. Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients
11. Oramed Pharmaceuticals Commences Phase 2A Trials of its Oral Insulin Capsule on Type 1 Diabetics

Post Your Comments:

(Date:5/21/2013)... 2013 Lakeland Industries, Inc. (NASDAQ: ... protective clothing for industry, municipalities, healthcare and first ... today announced that the Company accepted a commitment ... Facility subject to certain terms and conditions and ... no assurances can be given that this transaction ...

(Date:5/21/2013)... 21, 2013 Tom Daulton, CEO of Mammotome, a division ... Year by the Cincinnati chapter of ... by another local top executive who is also a breast ... Ethicon Endo-Surgery in March of 2010. Daulton will be presented ... presented by Huntington Bank, on May 22. The ...

(Date:5/21/2013)... Kepner-Tregoe (KT), the global capability development ... Chris Geraghty has been ... than 20 years serving the industrial sector, holding ... succeeds Ray Baxter , who ... the Board and CEO. (Logo: ...

[0] Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results [0] Tom Daulton, Mammotome CEO, Named ACG Dealmaker of the Year [0] Kepner-Tregoe, Inc. Promotes Chris Geraghty to Chief Executive Officer

... 14, 2011 /PRNewswire / -- Nephros, Inc. (OTC Bulletin Board: ... three months ended September 30, 2011. Recent ... associated with Rights Offering to be exercised; Received initial ... Hemodiafiltration System in U.S. Financial ...

... 14, 2011 Landauer, Inc. (NYSE: LDR ... radiation monitoring and the leading domestic provider of outsourced ... all of the outstanding equity interests of IZI Medical ... a purchase price of approximately $93 million. IZI Medical ...

Cached Medicine Technology:Nephros Reports Third Quarter 2011 Financial Results 2 Nephros Reports Third Quarter 2011 Financial Results 3 Nephros Reports Third Quarter 2011 Financial Results 4 Nephros Reports Third Quarter 2011 Financial Results 5 Landauer, Inc. Announces Acquisition of IZI Medical Products, LLC 2 Landauer, Inc. Announces Acquisition of IZI Medical Products, LLC 3 Landauer, Inc. Announces Acquisition of IZI Medical Products, LLC 4 Landauer, Inc. Announces Acquisition of IZI Medical Products, LLC 5 Landauer, Inc. Announces Acquisition of IZI Medical Products, LLC 6

Nephros Reports Third Quarter 2011 Financial Results Landauer, Inc. Announces Acquisition of IZI Medical Products, LLC

(Date:5/21/2013)... ContinuCare Home Health, Inc. recently received a ... Disability Services. After completing a four-day review of patient ... Health was found to have no deficiencies to be ... Department of Aging and Disability Services’ mission to provide ... and opportunities that are easily accessed in local ...

(Date:5/21/2013)... Beach, CA (PRWEB) May 21, 2013 ... 3rd Annual EB-5 Investment Summit: Dealmakers Conference in ... Dealmakers Conference will focus on exploring alternative finance ... provide the latest market, legal and economic information, ... immigration and legal professionals within the EB-5 industry. ...

(Date:5/21/2013)... According to a May 13, 2013 New Zealand ... Botox injections have become the most popular cosmetic ... to goo.gl/8iYbD). Although it is mostly associated with women, ... makes facial wrinkles less visible by paralyzing facial muscles. The ... months. This means that people who are conscious about their ...

(Date:5/21/2013)... Focus, a non-profit organization striving to improve the living ... Corridor region, is releasing results for its 2013 Creative ... May 23rd at 10:30 a.m. The survey follows ... The survey is a critical component to the organizations’ ... and retain people of diverse backgrounds, cultures and beliefs ...

(Date:5/21/2013)... A paper recently published in the New England ... scientists at the University of Colorado School of Medicine ... fibrosis can be used to identify individuals at risk ... a fairly common variant of the gene for mucin-5B, ... produced by the bronchial tubes. While this variant of ...

Breaking Medicine News(10 mins):Health News:ContinuCare Home Health, Inc. Receives Perfect Report from the Texas Department of Aging and Disability Services 2 Health News:Artisan Business Group to Host EB-5 Investment Conference in Long Beach, California 2 Health News:Botox – Is the World’s Most Popular Cosmetic Procedure Safe? 2 Health News:Diversity Focus Announces Results from 2013 Creative Corridor Survey at News Conference on Thursday, May 23rd at 10:30 a.m. 2 Health News:Researchers find genetic risk factor for pulmonary fibrosis 2

[0] ContinuCare Home Health, Inc. Receives Perfect Report from the Texas Department of Aging and Disability Services [0] Artisan Business Group to Host EB-5 Investment Conference in Long Beach, California [0] Botox – Is the World’s Most Popular Cosmetic Procedure Safe?[0] Diversity Focus Announces Results from 2013 Creative Corridor Survey at News Conference on Thursday, May 23rd at 10:30 a.m.[0] Researchers find genetic risk factor for pulmonary fibrosis

... 25 Toxic,substances, such as asbestos, lead, and PCBs, ... Particulates in the smoke plumes from the California ... the affected areas. Toxic substances in the smoke ... inside and outside of structures and the land,surrounding the ...

... ... exposure, SAN FRANCISCO, Oct. 25 ... and Surgeons,advise residents of Southern California who have been exposed to smoke ... to,smoke can cause irritation, with symptoms such as burning sensations,redness, and tearing. ...

... Earnings Per Share of $0.70; Sales Up 25%; Net Earnings up ... $65 Million; Operating Cash Flow of $91 Million, ... reported results for the third quarter ended September 30,2007 that again ... share (DEPS) were $0.70 compared to $0.56 in,the third quarter of ...

... Oct. 25 As of 1:00 p.m. PST,today, ... Miguel,Covenant Village retirement campus in Spring Valley. Emergency ... living,apartments and residents were transported to the campus ... Loma. The residents were evacuated late,Monday night. ...

... to treat individuals with cancer that is being developed ... cancer cells while leaving normal cells unharmed. These viruses ... Kirn and colleagues at Jennerex Biotherapeutics, San Francisco, have ... effects in both mice and rabbits. , After selecting ...

... is the lead research institution in a $3.89 million ... consequences on victims in disasters. , The consortium, ... includes researchers from U-M, Dartmouth Medical School, Medical University ... Oklahoma. The center is funded by the National Institutes ...

California Wildfires - The Hidden Dangers & Actions You Can Take Wildfire Smoke Can Be a Threat to Eyes Roper Industries Announces Record Third Quarter Results Retirement Residents Return Home How to design a cancer-killing virus U-M to lead disaster aftermath research center

Contoured waterfall-front ergonomic seats and generous backrests with lumbar support are standard on these ergonomic chairs. • Not available with casters • With Tubular Base....

Contoured waterfall-front ergonomic seats and generous backrests with lumbar support are standard on these ergonomic chairs. • With casters • With Tubular Base....

Medicine Products:

4V63 4V61-R 4V42-R 4V58-R